Cubist Pharmaceuticals - antibiotic and antimicrobial therapies for MRSA and other super bugs such as Clostridium-difficile and multi-drug resistant Gram-negative pathogens and other novel therapies for use in hospital and other acute care settings

1Q10 Results

Replay of Cubist's April 15, 2010 earnings call that reported on Cubist's 1Q10 results and discussed 2010 guidance and expected milestones
Transcript of the April 15, 2010 earnings call
Presentation slides that accompanied the April 15, 2010 earnings call

4Q & FY09 Results

Replay of Cubists January 21, 2010 earnings call that reported on Cubists 4Q/FY09 results and discussed 2010 guidance and expected milestones
Transcript of the January 21, 2010 earnings call
Presentation slides that accompanied the January 21, 2010 earnings call

Learn More About Cubist »

Press Release » Mike Bonney's remarks » Tribute video »

Learn about Cubist recent results and 2010 plans »

Cubist Pharmaceuticals and the New England Patriots Radio Network Renew Program to Recognize Innovative Science Teachers

Posted July 19, 2010

LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it is - for the second year in a row - teaming up with the New England Patriots Radio Network,

Investor Center

CBST(NASDAQ)

Cubist Pharmaceuticals, Inc.

Last Price

(4:00pm)

22.45

0.16

Cubist Investor Relations » Earnings Call Information »

Advancing Pipeline

CXA-201 Gram Negative »

Phase 2

See More Products in the Pipeline »